Pharmaceuticals stories
Plant operators can now connect mixed equipment more easily as Yokogawa adds multi-vendor support and tighter security to its OpreX server.
It underscores Fuel's push to tighten its systems and cyber defences as North American logistics operators face rising pressure for speed and visibility.
Field sales teams will get AI-generated call plans in seconds as Sanofi expands Snowflake use across research, procurement and operations.
The platform targets manual drug-development bottlenecks, from trial documents to safety case intake, as biopharma seeks faster compliant workflows.
The rankings bolster Altimetrik's push to win larger contracts from drugmakers as life sciences firms seek AI that improves regulated operations.
Industrial operators may get faster AI access to plant and business data, as the deal avoids copying information into separate systems.
QuEra survey finds quantum buyers and backers are demanding stronger proof of value, even as 46% of organisations expect budgets to stay flat.
The new specialisation should help healthcare and life sciences firms use governed AI and data tools to speed trials, discovery and patient insights.
AI in life sciences is boosting workflows rather than replacing scientists, as firms navigate regulation, data risks and uneven adoption across markets.
Neoqura hires The Optimisers for US expansion as it readies Asteroid Ointment, backed by a NZD $2 million crowdfunding plan.
Life sciences firms could avoid costly FDA review delays as the software flags conflicting claims across filings before submissions are sent.
The new tools give life sciences finance teams clearer trial spending forecasts and scenario planning after a USD $24 million Series A round.
Practical use, not price, is now the main hurdle for quantum AI adoption, as SAS readies a tool for Viya customers later this year.
Artificial intelligence has become the main driver of UK tech value, with venture funding and start-up creation increasingly concentrated in the sector.
The funding will help London-based Apoha commercialise a liquid data layer already used by Boehringer Ingelheim and other pharma groups.
The hire strengthens ThreeSixty's push to meet rising demand for supply chain modelling as retailers and manufacturers seek lower freight costs.
The platform is aimed at regulated industries and sensitive data users, with on-premise and air-gapped deployment to keep control in-house.
Enterprise AI projects across Europe will move beyond pilots as the tie-up targets secure deployment inside core business processes.
The AUD $490 million Waterloo precinct is set to ease Sydney’s lab space shortage as it moves into delivery with major global partners.
The funding could help turn hospital infusions into self-injectable treatments, as the London-founded firm scales microgravity drug crystallisation.